A process for preparing a pharmaceutical composition containing the fibrinolytic agent urokinase and hyaluronidase diffusionsfaktoren

摘要

The association of a fibrinolytic agent and of a diffusion factor has been shown very useful in the treatment of myocardial infarction. It has been shown that it is very useful to administer urokinase and hyaluronidase in the quantity ratio of at least 8 to 1, the quantity of each compound being expressed in the appropriate international units.